Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taj Mohammad

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
ACS Omega|August 11, 2020
Biophysical Insights into Implications of PEG-400 on the α-Crystallin Structure: Multispectroscopic and Microscopic ApproachAnas Shamsi, Taj Mohammad, Saleha Anwar, et al.
Plos One|August 5, 2025
Structure-based identification of bioactive compounds as trace amine-associated receptor 1 agonists for the therapeutic management of major depressive disorderAbdelbaset Mohamed Elasbali, Ahmed S Ali, Mohd Adnan, et al.
Journal of Molecular Neuroscience : MN|August 7, 2025
Aggregation-Prone Pathogenic SOD1 Variants in Amyotrophic Lateral Sclerosis: Insights from Computational Genomics and Evolutionary ConservationFarah Anjum, Maha M Bakhuraysah, Maram Jameel Hulbah, et al.
Scientific Reports|December 24, 2025
Identification of bioactive phytoconstituents as promising ABL2 inhibitors using virtual screening and molecular dynamics simulationAfnan Elayyan Mousa Elayyan, Abdelbaset Mohamed Elasbali, Marwah Ayed Meshhin Alanazi, et al.
Omics : a Journal of Integrative Biology|January 10, 2025
Phytochemicals Withanolide N and Dryobalanolide as Potential Bioactive Leads for Developing Anticancer Drugs Targeting Tyrosine-Protein Kinase MerAfzal Hussain, Taj Mohammad, Mehak Gulzar, et al.
Journal of Alzheimer'S Disease : JAD|January 15, 2025
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's diseaseMohammad Taufeeq, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Biomolecular Structure & Dynamics|January 7, 2020
Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancerTaj Mohammad, Kaynat Arif, Mohamed F Alajmi, et al.
Discovery Medicine|January 26, 2024
Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in CancerDeeba Shamim Jairajpuri, Taj Mohammad, Afzal Hussain, et al.
Journal of Biomolecular Structure & Dynamics|November 1, 2022
Unravelling hub genes as potential therapeutic targets in lung cancer using integrated transcriptomic meta-analysis and in silico approachAiman Mushtaq, Prithvi Singh, Gulnaz Tabassum, et al.
Journal of Ayub Medical College, Abbottabad : JAMC|March 30, 2012
Outcome of the rubber band ligation with Milligan Morgan haemorrhoidectomySyed Asad Ali, Agha Taj Mohammad, Mohammad Jarwar, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
ACS Omega|August 11, 2020
Biophysical Insights into Implications of PEG-400 on the α-Crystallin Structure: Multispectroscopic and Microscopic ApproachAnas Shamsi, Taj Mohammad, Saleha Anwar, et al.
Plos One|August 5, 2025
Structure-based identification of bioactive compounds as trace amine-associated receptor 1 agonists for the therapeutic management of major depressive disorderAbdelbaset Mohamed Elasbali, Ahmed S Ali, Mohd Adnan, et al.
Journal of Molecular Neuroscience : MN|August 7, 2025
Aggregation-Prone Pathogenic SOD1 Variants in Amyotrophic Lateral Sclerosis: Insights from Computational Genomics and Evolutionary ConservationFarah Anjum, Maha M Bakhuraysah, Maram Jameel Hulbah, et al.
Scientific Reports|December 24, 2025
Identification of bioactive phytoconstituents as promising ABL2 inhibitors using virtual screening and molecular dynamics simulationAfnan Elayyan Mousa Elayyan, Abdelbaset Mohamed Elasbali, Marwah Ayed Meshhin Alanazi, et al.
Omics : a Journal of Integrative Biology|January 10, 2025
Phytochemicals Withanolide N and Dryobalanolide as Potential Bioactive Leads for Developing Anticancer Drugs Targeting Tyrosine-Protein Kinase MerAfzal Hussain, Taj Mohammad, Mehak Gulzar, et al.
Journal of Alzheimer'S Disease : JAD|January 15, 2025
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's diseaseMohammad Taufeeq, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Biomolecular Structure & Dynamics|January 7, 2020
Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancerTaj Mohammad, Kaynat Arif, Mohamed F Alajmi, et al.
Discovery Medicine|January 26, 2024
Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in CancerDeeba Shamim Jairajpuri, Taj Mohammad, Afzal Hussain, et al.
Journal of Biomolecular Structure & Dynamics|November 1, 2022
Unravelling hub genes as potential therapeutic targets in lung cancer using integrated transcriptomic meta-analysis and in silico approachAiman Mushtaq, Prithvi Singh, Gulnaz Tabassum, et al.
Journal of Ayub Medical College, Abbottabad : JAMC|March 30, 2012
Outcome of the rubber band ligation with Milligan Morgan haemorrhoidectomySyed Asad Ali, Agha Taj Mohammad, Mohammad Jarwar, et al.
Pageof 15